These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9152779)

  • 41. Role of hepatitis C virus in cardiomyopathies.
    Matsumori A
    Ernst Schering Res Found Workshop; 2006; (55):99-120. PubMed ID: 16329660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. X-Linked Dilated Cardiomyopathy Presenting as Acute Rhabdomyolysis and Presumed Epstein-Barr Virus-Induced Viral Myocarditis: A Case Report.
    Malherbe JAJ; Davel S
    Am J Case Rep; 2018 Jun; 19():678-684. PubMed ID: 29891833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Apoptosis in the process from viral myocarditis to dilated cardiomyopathy].
    Satoh M; Hiramori K; Tamura G; Satodate R
    Nihon Rinsho; 1996 Jul; 54(7):1982-5. PubMed ID: 8741699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications.
    Sanchez MJ; Bergasa NV
    Med Sci Monit; 2008 May; 14(5):RA55-63. PubMed ID: 18443562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Viral infection and myocardial pathology].
    Paleev NR
    Vestn Ross Akad Med Nauk; 2006; (9-10):95-9. PubMed ID: 17111932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994.
    Strauer BE; Kandolf R; Mall G; Maisch B; Mertens T; Schwartzkopff B; Schultheiss HP
    Acta Cardiol; 1996; 51(4):347-71. PubMed ID: 8888893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The expression of dystrophin in human viral myocarditis and dilated cardiomyopathy].
    Xu HF; Li YH; Chen Y; Cheng LB
    Fa Yi Xue Za Zhi; 2006 Feb; 22(1):12-4. PubMed ID: 16524176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of transgenic knockout models in defining the pathogenesis of viral heart disease.
    Liu P; Penninger J; Aitken K; Sole M; Mak T
    Eur Heart J; 1995 Dec; 16 Suppl O():25-7. PubMed ID: 8682095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
    Matsumori A; Sasayama S
    Eur Heart J; 1995 Dec; 16 Suppl O():140-3. PubMed ID: 8682082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crosstalk Between Innate Immunity and Autophagy in Viral Myocarditis Leading to Dilated Cardiomyopathy.
    Wang C; Luo H
    Rev Med Virol; 2024 Nov; 34(6):e2586. PubMed ID: 39349889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis.
    Wolff PG; Kühl U; Schultheiss HP
    Am Heart J; 1989 Jun; 117(6):1303-9. PubMed ID: 2658521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
    Zhao L; Fu Z
    J Immunol Res; 2018; 2018():5301548. PubMed ID: 29854842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
    Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Virus and dilated cardiomyopathies].
    Bouhour JB; Langlard JM; Kopecka H; Petitjean J; Freymuth F
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():15-20. PubMed ID: 8215785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemistry in dilated cardiomyopathy.
    Kühl U; Noutsias M; Schultheiss HP
    Eur Heart J; 1995 Dec; 16 Suppl O():100-6. PubMed ID: 8682073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is hepatitis C virus a cause of idiopathic dilated cardiomyopathy? A systematic review of literature.
    Dos Reis FJ; de Sousa TA; Oliveira MS; Dantas N; Silveira M; Braghiroly MI; Paraná R
    Braz J Infect Dis; 2006 Jun; 10(3):199-202. PubMed ID: 17568853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.
    Kishimoto C; Shioji K; Kinoshita M; Iwase T; Tamaki S; Fujii M; Murashige A; Maruhashi H; Takeda S; Nonogi H; Hashimoto T
    Int J Cardiol; 2003 Oct; 91(2-3):173-8. PubMed ID: 14559127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Detection of viral genomes in myocarditis].
    Matsumori A
    Rinsho Byori; 1995 Apr; 43(4):358-64. PubMed ID: 7739117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.